Corey’s referees spoke of his audacious vision to tackle some of the greatest challenges in mental health and addiction through ‘software as medicine’. He is an eMental Health trailblazer. Drawing on his multidisciplinary expertise in neuroscience, biochemistry and technology, Cory relentlessly pursued building credible, evidence-based prescription digital therapeutics’ (PDTs) in his role as CEO of Pear Therapeutics.  This work led to the creation of a new FDA category for PDTs and the approval of the first three FDA authorizations for a PDT. Cory’s bold leadership, respect for the sciences and exemplary navigation of traditional health system stakeholder dynamics, has opened opportunities for eMental Health innovation and implementation across the US and the globe.   

Cory has and is transforming how we solve some of the most challenging problems in mental health: opioid use disorder (OUD), substance use disorder (SUD) and chronic insomnia. In the US alone, addiction affects more than 20 million people. Chronic insomnia is estimated to affect approximately 30 million people. His visionary leadership and exemplary implementation has led to his organization’s three eMental Health solutions being prescribed by health professionals in over 32 states in the US.  The Singapore Health Science Authority has also approved its SUD product, making it the first authorization of a PDT outside the US. 

Our referees quote Malcolm Gladwell…this “visionary starts with a clean sheet of paper, and reimagines the world”. We couldn’t agree more.  Cory is an exemplary health sector leader, highly worthy of this award and we join his referees in congratulating him whole-heartedly.